Isomaltooligosaccharide (tapioca)

A mildly sweet, starch-derived carbohydrate syrup/powder made of short glucose chains with mostly α-1,6 bonds; used to add bulk, bind, and sometimes count as fiber-like in some markets.

Should I eat Isomaltooligosaccharide (tapioca)?

Treat most IMO as a refined carbohydrate: it helps bars hold together and taste mildly sweet but often behaves like sugar in your body. If you want fiber‑like benefits, choose products with FDA‑recognized fibers instead.

Summary

Isomaltooligosaccharide (tapioca) is a starch‑derived bulking sweetener used to add chew and reduce sucrose in snacks and bars. Human trials show several IMO syrups are largely digestible and can produce glycemic and insulinemic responses similar to dextrose at equal carbohydrate loads. U.S. labeling rules generally do not count IMO as dietary fiber, so “fiber syrup” claims may overpromise fiber‑like effects. Safety reviews by EFSA and FDA support use in the general population (excluding infant foods), and most adults tolerate moderate single servings. Composition varies by brand, so check total and added sugars and consider portion size.

Key Research Benefits

Helps cut added sugar while keeping texture

Its mild sweetness and strong binding let makers reduce sucrose and keep bars cohesive and palatable.

Generally tolerated at moderate servings

Human data and GRAS reviews report single‑serving tolerance around 25 g (dry basis) for most adults.

Regulatory bodies consider it safe at intended uses

EFSA (2024) and multiple FDA GRAS notices raised no safety concerns for proposed uses (infant foods excluded in the EU).

Key Research Risks

Glycemic impact can be high

Some IMO syrups spike blood sugar and insulin similarly to dextrose when matched for carbohydrate.

Fiber claims may not apply

In the U.S., isolated carbs must show a health benefit to count as 'dietary fiber'; IMO generally does not qualify, so labels can overstate fiber‑like effects.

GI upset at high doses

Large servings may cause gas, bloating, or discomfort, particularly in people with sensitive guts.

Overview

What is it?

Source: Cassava starch

Method: Liquefy & saccharify, transglycosylate, then purify

Processing Level: 7 / 10

Why is it used?

Purpose: Bulking sweetener and binder for texture.

Commonly found in: Protein bars, Fiber syrup, Granola, Cookies, Shakes

Why manufacturers choose it: Delivers bulk and chew with mild sweetness, enabling sugar‑reduction strategies in bars and snacks.

Origin

Commercial IMOs emerged from Japanese and broader starch-processing research in the late 20th century, using enzymes to rearrange starch sugars into α-1,6–linked oligosaccharides. Regulatory assessments (FSANZ 2016; EFSA 2024) describe widespread use in Asia and later adoption in North America and Europe for reduced-sugar foods.

Process: Liquefy & saccharify, transglycosylate, then purify

Steps

1. Liquefy: Make starch slurry and break it down with α-amylase (heat-stable) and pullulanase.

2. Transglycosylate: Use α-transglucosidase (and related enzymes) to convert α-1,4 to α-1,6 linkages forming IMO.

3. Ferment simple sugars: Yeast ferments residual mono-/disaccharides; yeast removed by filtration.

4. Purify: Decolorize with activated carbon; desalting/protein removal via ion-exchange.

5. Concentrate & dry: Evaporate to syrup or spray-dry to powder; package.

Chemicals

α-amylase (enzyme)

pullulanase (enzyme)

α-transglucosidase (enzyme)

yeast (processing aid)

activated carbon

ion-exchange resins

calcium chloride (pH/processing aid, reported in some processes)

Research & Safety

Research Summary

Isomaltooligosaccharide (IMO) is a mildly sweet carbohydrate made from cassava starch using enzymes that rearrange glucose units; manufacturers then purify it with steps like activated carbon and ion exchange. It is widely used in bars and reduced‑sugar snacks for bulk and binding. Despite being marketed in some places as a “fiber syrup,” a randomized crossover trial in healthy adults found the tested IMO syrups were largely digestible and produced blood‑glucose and insulin responses comparable to dextrose at equal carbohydrate loads, with little sign of fermentation. In the U.S., FDA only counts isolated carbohydrates as “dietary fiber” if they show specific health benefits, and IMO generally does not qualify under this policy. Practically, that means many IMOs act like refined carbs rather than true dietary fibers. Regulators have repeatedly reviewed IMO and consider it safe at intended uses: EFSA’s 2024 opinion supported extending uses in the EU (excluding infant foods), and multiple FDA GRAS notices received “no questions.” Human data and GRAS dossiers suggest most adults tolerate single servings around 25 g (dry basis), though larger amounts can cause gas or discomfort. Composition varies across products—some syrups include more mono‑ and disaccharides—so glycemic impact and GI tolerance can differ. For consumers, the safest approach is to treat most IMOs as digestible carbohydrate, watch total and added sugars on the Nutrition Facts label, and not rely on IMO for fiber‑like health effects.

Digestive Effects

Most adults tolerate a single serving around 25 g (dry basis), roughly equivalent to about 65–70 g of typical syrup, with few symptoms. Larger intakes may cause gas, bloating, or abdominal discomfort, and sensitivity varies by person and by product composition. Compared with classic fermentable fibers (like inulin), some IMO syrups show limited fermentation in breath tests, which may mean fewer gas‑related symptoms for some people. Individuals with IBS or on a low‑FODMAP approach may still be sensitive and should test tolerance cautiously. Splitting intake across the day and drinking water may help reduce GI symptoms.

Limit Consumption

Infants: EU/UK authorizations exclude infant formulas and infant foods, so avoid using IMO for infants. People with diabetes or prediabetes should count IMO toward carbohydrate intake and expect a glycemic response similar to other refined carbs. Those on low‑carb or ketogenic diets should include IMO in their net‑carb tally. People with IBS or sensitive digestion may experience GI symptoms at higher doses and may prefer alternative fibers. IMO is typically gluten‑free and not a top‑9 allergen, but always check product labels for cross‑contact statements.

Fact Sheet

Regulatory Status

US FDA: Multiple GRAS notices with ‘no questions’ (e.g., GRN 674, 2016; GRN 779, 2025).

EU Status: Authorized as a Novel Food; EFSA 2024 opinion confirms extension of uses (excludes infant foods).

Codex INS: None (ingredient, not a food additive with INS/E-number).

JECFA ADI: Not established (treated as carbohydrate ingredient).

ESG & Sustainability

Environmental Footprint: Impacts tied to cassava/corn cultivation and industrial enzyme/purification steps; lower transport mass for powders.

Sustainability: Cassava is drought-tolerant; sustainability depends on sourcing (deforestation risks vary by region) and wastewater management from purification.

Animal Welfare: Not animal-derived; enzymes produced via microbial fermentation.

Carbon Footprint: No specific LCA for IMO; expected similar to refined starch syrups; energy use from evaporation/drying is notable.

Allergens and Diet

Allergen Status: None

Diet Compatibility: Vegan, Vegetarian, Kosher, Halal, Gluten-free, Dairy-free

Natural Alternatives

Date paste

Source: Dates (fruit)

Processing Level: Light

Common Uses: Bars, cookies, smoothies

Replacement Benefit: Provides intrinsic fiber, potassium, and polyphenols from whole fruit.

Why it's not used: IMO is cheaper per sweetness unit, easier to meter and standardize, and offers cleaner handling vs sticky fruit pastes.

Chicory root fiber (inulin)

Source: Chicory root

Processing Level: Moderate

Common Uses: Fiber bars, cereals, yogurt

Replacement Benefit: Recognized by FDA as dietary fiber with demonstrated physiological benefits.

Why it's not used: IMO offers better binding/chew in some matrices and less GI gas for some users than high-dose inulin.

Soluble corn fiber

Source: Corn starch

Processing Level: Moderate

Common Uses: Bars, beverages, baked goods

Replacement Benefit: Often recognized as dietary fiber in the U.S. (meets FDA fiber criteria).

Why it's not used: IMO may deliver preferred texture/sweetness balance and label strategies outside the U.S.

Citations

Isomalto-oligosaccharide as a Novel Food – Risk & Technical Assessment (A1123)

2016-12-13

Food Standards Australia New Zealand • FSANZ

Extension of use of isomalto-oligosaccharide as a novel food

2024-02-05

EFSA NDA Panel • EFSA Journal

Gastrointestinal Tolerance and Glycemic Response of Isomaltooligosaccharides in Healthy Adults

2018-03-03

Gourineni V., Stewart M.L., Icoz D., Zimmer J.P. • Nutrients

GRAS Notice Letter – Isomalto-oligosaccharides (Ingredion)

2019-12-18

FDA • FDA CFSAN

GRAS Notice 674 – Isomalto-oligosaccharides (BioNeutra submission)

2016-10-11

FDA • FDA CFSAN

21 CFR 101.9 – Nutrition labeling of food (dietary fiber definition)

2024-07-01

U.S. Government Publishing Office • eCFR

Recently Published GRAS Notices and FDA Letters (GRN 779, IMO mixture – no questions)

2025-09-17

FDA • FDA